[Artigo] Indications of PCSK9 inhibitors for patients at high and very high cardiovascular risk

Autores: Paulo Eduardo Ballve Behr, Emilio Hideyuki Moriguchi, Iran Castro, Luiz Carlos Bodanese, Oscar Pereira Dutra, Paulo Ernesto Leães, Pedro Pimentel Filho

-

Arq. Bras. Cardiol. 2018 Jul:111(1):104-108

DOI: 10.5935/abc.20180133